233 related articles for article (PubMed ID: 10725342)
21. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
23. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Powell WC; Knox JD; Navre M; Grogan TM; Kittelson J; Nagle RB; Bowden GT
Cancer Res; 1993 Jan; 53(2):417-22. PubMed ID: 8417833
[TBL] [Abstract][Full Text] [Related]
24. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse.
Wilson CL; Heppner KJ; Rudolph LA; Matrisian LM
Mol Biol Cell; 1995 Jul; 6(7):851-69. PubMed ID: 7579699
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP.
Klein RD; Borchers AH; Sundareshan P; Bougelet C; Berkman MR; Nagle RB; Bowden GT
J Biol Chem; 1997 May; 272(22):14188-92. PubMed ID: 9162049
[TBL] [Abstract][Full Text] [Related]
26. Refolding and recovery of recombinant human matrix metalloproteinase 7 (matrilysin) from inclusion bodies expressed by Escherichia coli.
Oneda H; Inouye K
J Biochem; 1999 Nov; 126(5):905-11. PubMed ID: 10544284
[TBL] [Abstract][Full Text] [Related]
27. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
[TBL] [Abstract][Full Text] [Related]
28. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Itoh F; Yamamoto H; Hinoda Y; Imai K
Cancer; 1996 Apr; 77(8 Suppl):1717-21. PubMed ID: 8608568
[TBL] [Abstract][Full Text] [Related]
29. Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.
Surendran K; Simon TC; Liapis H; McGuire JK
Kidney Int; 2004 Jun; 65(6):2212-22. PubMed ID: 15149334
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Nagashima Y; Hasegawa S; Koshikawa N; Taki A; Ichikawa Y; Kitamura H; Misugi K; Kihira Y; Matuo Y; Yasumitsu H; Miyazaki K
Int J Cancer; 1997 Jul; 72(3):441-5. PubMed ID: 9247287
[TBL] [Abstract][Full Text] [Related]
31. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
Rivat C; Le Floch N; Sabbah M; Teyrol I; Redeuilh G; Bruyneel E; Mareel M; Matrisian LM; Crawford HC; Gespach C; Attoub S
FASEB J; 2003 Sep; 17(12):1721-3. PubMed ID: 12958188
[TBL] [Abstract][Full Text] [Related]
32. Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Kumar A; Collins H; Van Tam J; Scholefield JH; Watson SA
Eur J Cancer; 2002 Mar; 38(4):505-10. PubMed ID: 11872342
[TBL] [Abstract][Full Text] [Related]
33. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes.
Busiek DF; Ross FP; McDonnell S; Murphy G; Matrisian LM; Welgus HG
J Biol Chem; 1992 May; 267(13):9087-92. PubMed ID: 1374384
[TBL] [Abstract][Full Text] [Related]
34. Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Yamamoto H; Itoh F; Hinoda Y; Imai K
Int J Cancer; 1995 Apr; 61(2):218-22. PubMed ID: 7705951
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage.
Saarialho-Kere U; Kerkelä E; Jeskanen L; Hasan T; Pierce R; Starcher B; Raudasoja R; Ranki A; Oikarinen A; Vaalamo M
J Invest Dermatol; 1999 Oct; 113(4):664-72. PubMed ID: 10504457
[TBL] [Abstract][Full Text] [Related]
36. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Ichikawa Y; Ishikawa T; Momiyama N; Yamaguchi S; Masui H; Hasegawa S; Chishima T; Takimoto A; Kitamura H; Akitaya T; Hosokawa T; Mitsuhashi M; Shimada H
Clin Exp Metastasis; 1998 Jan; 16(1):3-8. PubMed ID: 9502072
[TBL] [Abstract][Full Text] [Related]
37. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.
Powell WC; Fingleton B; Wilson CL; Boothby M; Matrisian LM
Curr Biol; 1999 Dec 16-30; 9(24):1441-7. PubMed ID: 10607586
[TBL] [Abstract][Full Text] [Related]
38. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Bair EL; Massey CP; Tran NL; Borchers AH; Heimark RL; Cress AE; Bowden GT
Exp Cell Res; 2001 Nov; 270(2):259-67. PubMed ID: 11640889
[TBL] [Abstract][Full Text] [Related]
39. Coordinated expression of matrilysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA.
Sundareshan P; Koster JJ; Nagle RB; Bowden GT
Cancer Lett; 1997 Feb; 113(1-2):17-24. PubMed ID: 9065796
[TBL] [Abstract][Full Text] [Related]
40. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
